Penumbra (PEN) Accumulated Depreciation & Amortization (2014 - 2025)

Penumbra (PEN) reported Accumulated Depreciation & Amortization of $17.5 million for Q4 2025, down 26.29% year-over-year from $23.7 million in Q4 2024, and down 26.29% quarter-over-quarter from $23.7 million in Q4 2024.

Penumbra (PEN) Accumulated Depreciation & Amortization (2014 - 2025) Analysis & Trends

Penumbra (PEN) has 12 years of Accumulated Depreciation & Amortization data on file, last reported at $17.5 million in Q4 2025.

  • Accumulated Depreciation & Amortization for Q4 2025 came in at $17.5 million, down 26.29% year-over-year; the trailing twelve-month figure through Dec 2025 was $17.5 million (down 26.29% YoY), and the FY2025 annual result was $17.5 million, down 26.29% from the prior year.
  • Accumulated Depreciation & Amortization retreated to $17.5 million in Q4 2025 per PEN's latest filing, from $23.7 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $27.3 million in Q4 2023 and troughed at $13.3 million in Q2 2023.
  • A 5-year average of $19.7 million and a median of $19.3 million in 2024 frame the typical range for Accumulated Depreciation & Amortization.
  • The sharpest annual moves came in 2022 and 2025: Accumulated Depreciation & Amortization jumped 48.23% in 2022, then declined 26.29% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $16.4 million in 2021, then soared by 48.23% to $24.3 million in 2022, then advanced by 12.07% to $27.3 million in 2023, then retreated by 13.04% to $23.7 million in 2024, then decreased by 26.29% to $17.5 million in 2025.
  • Business Quant data shows PEN's Accumulated Depreciation & Amortization at $17.5 million in Q4 2025, $23.7 million in Q4 2024, and $19.3 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 Penumbra 12.51 Bn 11.90 Bn 253.41 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 17.47 Mn
Dec 31, 2025 17.47 Mn
Dec 31, 2024 23.70 Mn
Dec 31, 2024 23.70 Mn
Sep 30, 2024 19.31 Mn
Sep 30, 2024 19.31 Mn
Jun 30, 2024 15.17 Mn
Jun 30, 2024 15.17 Mn
Dec 31, 2023 27.26 Mn
Dec 31, 2023 27.26 Mn
Sep 30, 2023 20.22 Mn
Sep 30, 2023 20.22 Mn
Jun 30, 2023 13.29 Mn
Jun 30, 2023 13.29 Mn
Dec 31, 2022 24.32 Mn
Dec 31, 2022 24.32 Mn
Dec 31, 2021 16.41 Mn
Dec 31, 2021 16.41 Mn
Dec 31, 2020 12.89 Mn
Dec 31, 2020 12.89 Mn